DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Berria R, Glass L, Mahankali A, Miyazaki Y, Monroy A, De Filippis E, Cusi K, Cersosimo E, Defronzo RA, Gastaldelli A.
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus.
Clin Pharmacol Ther 2007; 82: 275-281
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.